3-(4-chloro-2-fluorobenzy1)-2-methyl-N-.(5-methyl-1H-pyrazol-3-y1)-8-(morpholinomethyDimidazo[1,2-b]pyridazin-6-amine compound
PK141039AUndetermined Publication Date: 2010-12-27ELI LILLY & CO
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200901071
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-12-27
Abstract
The present invention provides 3-(4-chloro-2-fluorobenzy1)-2-methyl-N-.(5-methyl-1H-pyrazol-3-y1)-8-(morpholinomethyDimidazo[1,2-b]pyridazin-6-amine compound useful in the treatment of chronic myeloproliferative disorders and various cancers, e.g., glioblastoma, breast cancer, multiple myeloma, prostate cancer, and leukemias.
Need to check novelty before this filing date? Find Prior Art